The AHN Transplant Institute uses groundbreaking techniques to help patients with cancerous liver tumors become candidates for transplant. To be eligible for a transplant, the number and size of the tumors must meet strict national guidelines set by the United Network for Organ Sharing.
A liver transplant becomes even more critical for these patients, because it is the only treatment that can remove both the cancerous tumors and the entire diseased liver. While patients are waiting for a liver transplant, we offer the most advanced cancer treatments to keep tumors from spreading.
Stereotactic body radiation therapy (SBRT) is a rapidly emerging, non-invasive technique for treating tumors. It allows for the precise delivery of high doses of radiation to isolated tumors to minimize damage to healthy tissue. Compared to traditional radiation, it is less toxic, has fewer side effects, and is more successful.
Under the guidance of Alexander Kirichenko, MD, PhD, a radiation oncologist, the AHN Cancer Institute is leading the field with this treatment. Liver SBRT is usually delivered as an outpatient treatment for four to five days.